查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1589598

药物输送市场：口服药物输送，按设备类型、分销管道、应用划分 - 2025-2030 年全球预测

Drug Delivery Market by Oral Drug Delivery (Injectable Drug Delivery, Nasal Drug Delivery, Ocular Drug Delivery), Device Type (Advanced, Conventional), Distribution Channels, Application - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 194 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年给药市值为17.2亿美元，预计到2024年将达到18.2亿美元，复合年增长率为6.41%，预计到2030年将达到26.5亿美元。

药物输送市场包括各种旨在以受控方式施用治疗物质以实现特定结果的技术。这对于提高药物疗效、患者依从性和安全性至关重要。药物传递系统包括锭剂和注射等传统载体，以及奈米粒子、脂质体和水凝胶等先进技术。药物（包括生技药品和个人化医疗）日益复杂，需要精确靶向和控制释放，这推动了对创新药物输送系统的需求。应用范围涵盖製药、生物技术、医院和诊所，最终使用场景专注于慢性病管理、癌症治疗、疫苗传输和诊断。

主要市场统计
基准年[2023] 17.2亿美元
预测年份 [2024] 18.2亿美元
预测年份 [2030] 26.5亿美元
复合年增长率（%） 6.41%

市场受到慢性病盛行率上升、技术进步和研发投资增加等因素的显着影响。物联网和人工智慧等智慧技术的集合成为建构智慧交付系统创造了机会，进一步提高准确性和监控能力。生物感测器和生物有效性增强剂代表了一条有前途的发展途径。为了利用这些机会，企业应专注于与高科技公司和研究机构的伙伴关係关係，以创新下一代交付平台。

然而，市场面临严格的法律规范和开发先进交付系统的高成本的限制，这阻碍了中小企业的发展。此外，诸如需要专业知识以及将新兴技术整合到现有框架中的复杂性等挑战构成了重大障碍。儘管如此，创新的时机已经成熟，包括开发针对个别患者情况的非侵入性给药方法和个人化给药系统，这将显着提高采用率。了解市场动态和消费者需求对于企业成功驾驭不断变化的环境至关重要。药物输送市场的特点是技术创新速度快、投资潜力大，企业准备克服监管和技术挑战，满足对高效和有效的治疗解决方案不断增长的需求，提供了广泛的商机。

市场动态：揭示快速发展的药物传输市场的关键市场洞察

供需的动态交互作用正在改变药物输送市场。了解这些不断变化的市场动态可以帮助企业做出明智的投资决策、策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时消费行为及其对製造成本的影响以及对采购趋势的影响。

  • 市场驱动因素
    • 全球生技药品的使用增加
    • 对有效药物输送机制的需求不断增长
    • 慢性病显着增加
  • 市场限制因素
    • 药品召回和失败的增加
    • 与药物相关的副作用和风险
  • 市场机会
    • 对具有成本效益的医疗的需求不断增长
    • 对居家照护和自我管理的兴趣日益浓厚
  • 市场问题
    • 价格压力与专利到期问题

波特五力：驾驭给药市场的策略工具

波特的五力框架是了解市场竞争格局的重要工具。波特的五力框架描述了评估公司竞争和探索策略机会的清晰方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解药物输送市场的外部影响

外部宏观环境因素在塑造给药市场的绩效动态发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并帮助他们做出积极主动的决策。

市场占有率分析：了解给药市场的竞争格局

对药物输送市场的详细市场占有率分析可以对供应商绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示自己的竞争定位。该分析揭示了市场集中、细分和整合的趋势，为供应商提供了製定策略决策所需的见解，以应对日益激烈的竞争。

FPNV 定位矩阵：药物传输市场供应商的绩效评估

FPNV定位矩阵是评估药物传输市场供应商的重要工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商，以确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析与建议：绘製药物输送市场的成功之路

对于旨在加强在全球市场的影响力的公司来说，药物输送市场的策略分析至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机，并取得长期成功。

该报告对涵盖关键焦点细分市场的市场进行了全面分析。

1. 市场渗透率：详细检视当前市场环境，主要企业的广泛资料，评估其在市场中的影响力和整体影响力。

2. 市场开拓：辨识新兴市场的成长机会，评估现有细分市场的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、主要产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策。

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品和地区提供最佳投资机会？

3.塑造市场的关键技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 世界各地生物药物的使用增加
      • 对有效药物输送机制的需求不断增长
      • 慢性病显着增加
    • 抑制因素
      • 药品召回和缺陷增加
      • 与药物相关的副作用和风险
    • 机会
      • 对具有成本效益的医疗的需求不断增长
      • 越来越注重居家照护和自我管理
    • 任务
      • 价格压力与专利到期问题
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治
    • 经济
    • 社会
    • 科技
    • 法律
    • 环境

第六章 给药市场：口服给药

  • 介绍
  • 注射给药
  • 鼻腔给药
  • 眼部药物输送
  • 肺部药物输送
  • 局部给药

第七章药物输送市场：依设备类型

  • 介绍
  • 高级型
  • 传统的

第八章 药物传输市场：依通路分类

  • 介绍
  • 医院药房
  • 零售药房

第九章 药物传输市场：依应用分类

  • 介绍
  • 癌症
  • 心血管疾病
  • 糖尿病
  • 呼吸系统疾病

第十章美洲给药市场

  • 介绍
  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十一章亚太药物传输市场

  • 介绍
  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十二章欧洲、中东和非洲的给药市场

  • 介绍
  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十三章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议

公司名单

  • Antares Pharma, Inc. by Halozyme Therapeutics, Inc.
  • B. Braun SE
  • Baxter International Inc.
  • Becton, Dickinson and Company
  • Enable Injections, Inc.
  • Gerresheimer AG
  • Johnson & Johnson Services Inc.
  • Kindeva Drug Delivery
  • Koninklijke Philips NV
  • Merck KGaA
  • Novartis AG
  • nsulet Corporation
  • OraSure Technologies, Inc.
  • Oxford BioMedica PLC
  • Sanofi SA
Product Code: MRR-434CCDA05153

The Drug Delivery Market was valued at USD 1.72 billion in 2023, expected to reach USD 1.82 billion in 2024, and is projected to grow at a CAGR of 6.41%, to USD 2.65 billion by 2030.

The drug delivery market encompasses a range of technologies aimed at administering therapeutic substances in a controlled manner to achieve specific outcomes. This is crucial for improving drug efficacy, patient compliance, and safety. Drug delivery systems can include advanced methodologies like nanoparticles, liposomes, and hydrogels, alongside traditional mediums such as tablets and injections. The necessity of innovative drug delivery systems stems from the increasing complexity of pharmaceuticals, including biologics and personalized medicine, which require precise targeting and controlled release. Applications span across pharmaceuticals, biotechnology, hospitals, and clinics, with end-use scenarios focusing on chronic disease management, cancer therapy, vaccine delivery, and diagnostics.

KEY MARKET STATISTICS
Base Year [2023] USD 1.72 billion
Estimated Year [2024] USD 1.82 billion
Forecast Year [2030] USD 2.65 billion
CAGR (%) 6.41%

The market is significantly influenced by factors such as the rising prevalence of chronic diseases, technological advancements, and increased investment in R&D. Opportunities are emerging through the integration of smart technologies like IoT and AI to create intelligent delivery systems that further enhance precision and monitoring capabilities. Biosensors and bioavailability boosters present promising avenues for development. To capitalize on these opportunities, companies should focus on collaborative partnerships with tech firms and research institutions to innovate next-generation delivery platforms.

However, the market faces limitations from stringent regulatory frameworks and the high cost of developing advanced delivery systems, which can impede smaller companies. Moreover, challenges such as the need for specialized knowledge and the complexity of integrating emerging technologies into existing frameworks also pose significant hurdles. Despite these, areas ripe for innovation include the development of non-invasive delivery methods and personalized drug delivery systems tailored to individual patient profiles, which can significantly enhance adoption rates. Understanding market dynamics and consumer needs will be critical for companies to navigate the shifting landscape successfully. The drug delivery market, characterized by its rapid innovation pace and high investment potential, offers broad opportunities for companies that can overcome regulatory and technological challenges to meet growing demand for efficient and effective treatment solutions.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Drug Delivery Market

The Drug Delivery Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing use of biological drugs worldwide
    • Swelling demand for effective drug delivery mechanisms
    • Significant increase in chronic diseases
  • Market Restraints
    • Increasing drug recalls and drug failures
    • Side effects and risk associated with the drugs
  • Market Opportunities
    • Rising demand for cost-effective healthcare treatment
    • Growing focus towards home care and self-administration
  • Market Challenges
    • Pricing pressure and issues with patents expiry

Porter's Five Forces: A Strategic Tool for Navigating the Drug Delivery Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Drug Delivery Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Drug Delivery Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Drug Delivery Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Drug Delivery Market

A detailed market share analysis in the Drug Delivery Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Drug Delivery Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Drug Delivery Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Drug Delivery Market

A strategic analysis of the Drug Delivery Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Drug Delivery Market, highlighting leading vendors and their innovative profiles. These include Antares Pharma, Inc. by Halozyme Therapeutics, Inc., B. Braun SE, Baxter International Inc., Becton, Dickinson and Company, Enable Injections, Inc., Gerresheimer AG, Johnson & Johnson Services Inc., Kindeva Drug Delivery, Koninklijke Philips N.V., Merck KGaA, Novartis AG, nsulet Corporation, OraSure Technologies, Inc., Oxford BioMedica PLC, and Sanofi S.A..

Market Segmentation & Coverage

This research report categorizes the Drug Delivery Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Oral Drug Delivery, market is studied across Injectable Drug Delivery, Nasal Drug Delivery, Ocular Drug Delivery, Pulmonary Drug Delivery, and Topical Drug Delivery.
  • Based on Device Type, market is studied across Advanced and Conventional.
  • Based on Distribution Channels, market is studied across Hospital Pharmacies and Retail Pharmacies.
  • Based on Application, market is studied across Cancer, Cardiovascular Diseases, Diabetes, and Respiratory Diseases.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing use of biological drugs worldwide
      • 5.1.1.2. Swelling demand for effective drug delivery mechanisms
      • 5.1.1.3. Significant increase in chronic diseases
    • 5.1.2. Restraints
      • 5.1.2.1. Increasing drug recalls and drug failures
      • 5.1.2.2. Side effects and risk associated with the drugs
    • 5.1.3. Opportunities
      • 5.1.3.1. Rising demand for cost-effective healthcare treatment
      • 5.1.3.2. Growing focus towards home care and self-administration
    • 5.1.4. Challenges
      • 5.1.4.1. Pricing pressure and issues with patents expiry
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Drug Delivery Market, by Oral Drug Delivery

  • 6.1. Introduction
  • 6.2. Injectable Drug Delivery
  • 6.3. Nasal Drug Delivery
  • 6.4. Ocular Drug Delivery
  • 6.5. Pulmonary Drug Delivery
  • 6.6. Topical Drug Delivery

7. Drug Delivery Market, by Device Type

  • 7.1. Introduction
  • 7.2. Advanced
  • 7.3. Conventional

8. Drug Delivery Market, by Distribution Channels

  • 8.1. Introduction
  • 8.2. Hospital Pharmacies
  • 8.3. Retail Pharmacies

9. Drug Delivery Market, by Application

  • 9.1. Introduction
  • 9.2. Cancer
  • 9.3. Cardiovascular Diseases
  • 9.4. Diabetes
  • 9.5. Respiratory Diseases

10. Americas Drug Delivery Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Drug Delivery Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Drug Delivery Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Antares Pharma, Inc. by Halozyme Therapeutics, Inc.
  • 2. B. Braun SE
  • 3. Baxter International Inc.
  • 4. Becton, Dickinson and Company
  • 5. Enable Injections, Inc.
  • 6. Gerresheimer AG
  • 7. Johnson & Johnson Services Inc.
  • 8. Kindeva Drug Delivery
  • 9. Koninklijke Philips N.V.
  • 10. Merck KGaA
  • 11. Novartis AG
  • 12. nsulet Corporation
  • 13. OraSure Technologies, Inc.
  • 14. Oxford BioMedica PLC
  • 15. Sanofi S.A.

LIST OF FIGURES

  • FIGURE 1. DRUG DELIVERY MARKET RESEARCH PROCESS
  • FIGURE 2. DRUG DELIVERY MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL DRUG DELIVERY MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL DRUG DELIVERY MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL DRUG DELIVERY MARKET SIZE, BY ORAL DRUG DELIVERY, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL DRUG DELIVERY MARKET SIZE, BY ORAL DRUG DELIVERY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNELS, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNELS, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES DRUG DELIVERY MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES DRUG DELIVERY MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. DRUG DELIVERY MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. DRUG DELIVERY MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. DRUG DELIVERY MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL DRUG DELIVERY MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL DRUG DELIVERY MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. DRUG DELIVERY MARKET DYNAMICS
  • TABLE 7. GLOBAL DRUG DELIVERY MARKET SIZE, BY ORAL DRUG DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL DRUG DELIVERY MARKET SIZE, BY INJECTABLE DRUG DELIVERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL DRUG DELIVERY MARKET SIZE, BY NASAL DRUG DELIVERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL DRUG DELIVERY MARKET SIZE, BY OCULAR DRUG DELIVERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL DRUG DELIVERY MARKET SIZE, BY PULMONARY DRUG DELIVERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL DRUG DELIVERY MARKET SIZE, BY TOPICAL DRUG DELIVERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL DRUG DELIVERY MARKET SIZE, BY ADVANCED, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL DRUG DELIVERY MARKET SIZE, BY CONVENTIONAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL DRUG DELIVERY MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL DRUG DELIVERY MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL DRUG DELIVERY MARKET SIZE, BY CANCER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL DRUG DELIVERY MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL DRUG DELIVERY MARKET SIZE, BY DIABETES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL DRUG DELIVERY MARKET SIZE, BY RESPIRATORY DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS DRUG DELIVERY MARKET SIZE, BY ORAL DRUG DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 29. ARGENTINA DRUG DELIVERY MARKET SIZE, BY ORAL DRUG DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 30. ARGENTINA DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 31. ARGENTINA DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 32. ARGENTINA DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 33. BRAZIL DRUG DELIVERY MARKET SIZE, BY ORAL DRUG DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 34. BRAZIL DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 35. BRAZIL DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 36. BRAZIL DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 37. CANADA DRUG DELIVERY MARKET SIZE, BY ORAL DRUG DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 38. CANADA DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 39. CANADA DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 40. CANADA DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 41. MEXICO DRUG DELIVERY MARKET SIZE, BY ORAL DRUG DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 42. MEXICO DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 43. MEXICO DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 44. MEXICO DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 45. UNITED STATES DRUG DELIVERY MARKET SIZE, BY ORAL DRUG DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 46. UNITED STATES DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 47. UNITED STATES DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 48. UNITED STATES DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 49. UNITED STATES DRUG DELIVERY MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 50. ASIA-PACIFIC DRUG DELIVERY MARKET SIZE, BY ORAL DRUG DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 51. ASIA-PACIFIC DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 52. ASIA-PACIFIC DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 53. ASIA-PACIFIC DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 54. ASIA-PACIFIC DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 55. AUSTRALIA DRUG DELIVERY MARKET SIZE, BY ORAL DRUG DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 56. AUSTRALIA DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 57. AUSTRALIA DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 58. AUSTRALIA DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 59. CHINA DRUG DELIVERY MARKET SIZE, BY ORAL DRUG DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 60. CHINA DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 61. CHINA DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 62. CHINA DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 63. INDIA DRUG DELIVERY MARKET SIZE, BY ORAL DRUG DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 64. INDIA DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 65. INDIA DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 66. INDIA DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 67. INDONESIA DRUG DELIVERY MARKET SIZE, BY ORAL DRUG DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 68. INDONESIA DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 69. INDONESIA DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 70. INDONESIA DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 71. JAPAN DRUG DELIVERY MARKET SIZE, BY ORAL DRUG DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 72. JAPAN DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 73. JAPAN DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 74. JAPAN DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 75. MALAYSIA DRUG DELIVERY MARKET SIZE, BY ORAL DRUG DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 76. MALAYSIA DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 77. MALAYSIA DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 78. MALAYSIA DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 79. PHILIPPINES DRUG DELIVERY MARKET SIZE, BY ORAL DRUG DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 80. PHILIPPINES DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 81. PHILIPPINES DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 82. PHILIPPINES DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 83. SINGAPORE DRUG DELIVERY MARKET SIZE, BY ORAL DRUG DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 84. SINGAPORE DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 85. SINGAPORE DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 86. SINGAPORE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 87. SOUTH KOREA DRUG DELIVERY MARKET SIZE, BY ORAL DRUG DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 88. SOUTH KOREA DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 89. SOUTH KOREA DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 90. SOUTH KOREA DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 91. TAIWAN DRUG DELIVERY MARKET SIZE, BY ORAL DRUG DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 92. TAIWAN DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 93. TAIWAN DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 94. TAIWAN DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 95. THAILAND DRUG DELIVERY MARKET SIZE, BY ORAL DRUG DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 96. THAILAND DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 97. THAILAND DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 98. THAILAND DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 99. VIETNAM DRUG DELIVERY MARKET SIZE, BY ORAL DRUG DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 100. VIETNAM DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 101. VIETNAM DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 102. VIETNAM DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 103. EUROPE, MIDDLE EAST & AFRICA DRUG DELIVERY MARKET SIZE, BY ORAL DRUG DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 104. EUROPE, MIDDLE EAST & AFRICA DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 105. EUROPE, MIDDLE EAST & AFRICA DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 106. EUROPE, MIDDLE EAST & AFRICA DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 107. EUROPE, MIDDLE EAST & AFRICA DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 108. DENMARK DRUG DELIVERY MARKET SIZE, BY ORAL DRUG DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 109. DENMARK DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 110. DENMARK DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 111. DENMARK DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 112. EGYPT DRUG DELIVERY MARKET SIZE, BY ORAL DRUG DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 113. EGYPT DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 114. EGYPT DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 115. EGYPT DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 116. FINLAND DRUG DELIVERY MARKET SIZE, BY ORAL DRUG DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 117. FINLAND DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 118. FINLAND DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 119. FINLAND DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 120. FRANCE DRUG DELIVERY MARKET SIZE, BY ORAL DRUG DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 121. FRANCE DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 122. FRANCE DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 123. FRANCE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 124. GERMANY DRUG DELIVERY MARKET SIZE, BY ORAL DRUG DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 125. GERMANY DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 126. GERMANY DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 127. GERMANY DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 128. ISRAEL DRUG DELIVERY MARKET SIZE, BY ORAL DRUG DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 129. ISRAEL DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 130. ISRAEL DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 131. ISRAEL DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 132. ITALY DRUG DELIVERY MARKET SIZE, BY ORAL DRUG DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 133. ITALY DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 134. ITALY DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 135. ITALY DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 136. NETHERLANDS DRUG DELIVERY MARKET SIZE, BY ORAL DRUG DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 137. NETHERLANDS DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 138. NETHERLANDS DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 139. NETHERLANDS DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 140. NIGERIA DRUG DELIVERY MARKET SIZE, BY ORAL DRUG DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 141. NIGERIA DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 142. NIGERIA DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 143. NIGERIA DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 144. NORWAY DRUG DELIVERY MARKET SIZE, BY ORAL DRUG DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 145. NORWAY DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 146. NORWAY DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 147. NORWAY DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 148. POLAND DRUG DELIVERY MARKET SIZE, BY ORAL DRUG DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 149. POLAND DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 150. POLAND DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 151. POLAND DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 152. QATAR DRUG DELIVERY MARKET SIZE, BY ORAL DRUG DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 153. QATAR DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 154. QATAR DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 155. QATAR DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 156. RUSSIA DRUG DELIVERY MARKET SIZE, BY ORAL DRUG DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 157. RUSSIA DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 158. RUSSIA DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 159. RUSSIA DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 160. SAUDI ARABIA DRUG DELIVERY MARKET SIZE, BY ORAL DRUG DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 161. SAUDI ARABIA DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 162. SAUDI ARABIA DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 163. SAUDI ARABIA DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 164. SOUTH AFRICA DRUG DELIVERY MARKET SIZE, BY ORAL DRUG DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 165. SOUTH AFRICA DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 166. SOUTH AFRICA DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 167. SOUTH AFRICA DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 168. SPAIN DRUG DELIVERY MARKET SIZE, BY ORAL DRUG DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 169. SPAIN DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 170. SPAIN DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 171. SPAIN DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 172. SWEDEN DRUG DELIVERY MARKET SIZE, BY ORAL DRUG DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 173. SWEDEN DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 174. SWEDEN DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 175. SWEDEN DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 176. SWITZERLAND DRUG DELIVERY MARKET SIZE, BY ORAL DRUG DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 177. SWITZERLAND DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 178. SWITZERLAND DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 179. SWITZERLAND DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 180. TURKEY DRUG DELIVERY MARKET SIZE, BY ORAL DRUG DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 181. TURKEY DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 182. TURKEY DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 183. TURKEY DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 184. UNITED ARAB EMIRATES DRUG DELIVERY MARKET SIZE, BY ORAL DRUG DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 185. UNITED ARAB EMIRATES DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 186. UNITED ARAB EMIRATES DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 187. UNITED ARAB EMIRATES DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 188. UNITED KINGDOM DRUG DELIVERY MARKET SIZE, BY ORAL DRUG DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 189. UNITED KINGDOM DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 190. UNITED KINGDOM DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 191. UNITED KINGDOM DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 192. DRUG DELIVERY MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 193. DRUG DELIVERY MARKET, FPNV POSITIONING MATRIX, 2023